This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-CD27 monoclonal antibody, clone P434 [PE]
catalog :
DCABH-3082
quantity :
50 Tests
clonality :
monoclonal
host :
mouse
conjugate :
PE
clone name :
P434
reactivity :
human
application :
flow cytometry
product information
Cat :
DCABH-3082
Product Name :
Anti-CD27 monoclonal antibody, clone P434 [PE]
Brand :
Creative Diagnostics
Abbr :
Anti-CD27 MAb, PE-Conjugated
Host animal :
Mouse
Clone :
P434
Official Symbol :
CD27
Clonality :
Monoclonal
Application :
FC
Target :
CD27
Species Reactivity :
Human
Conjugate :
PE
Antibody Type :
Primary Antibodies
Immunogen :
The details of the immunogen for this antibody are not available.
Alternative Names :
CD27; CD27 molecule; TNFRSF7, tumor necrosis factor receptor superfamily, member 7; CD27 antigen; S152; Tp55; CD27L receptor; T cell activation antigen S152; T-cell activation antigen CD27; tumor necrosis factor receptor superfamily, member 7; T14; TNFRS
UniProt ID :
P26842
Antibody Isotype :
IgG1
Size :
50 Tests
Storage :
Store at +4°C.
company information
Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments